Fig. 6
From: Clinical significance and mechanisms associated with segmental UPD
Possible inversion recombinant correction in case 3. A NIPT study, referred due to a cardiac lesion, showing a terminal deletion of 1p and a duplication of terminal 1q (A), with both equivalent to the 13% fetal fraction, consistent with non-mosaic fetal alterations. B Subsequent microarray analysis at 23 weeks of gestation showed no dosage changes of chromosome 1, although a 21.58 Mb terminal 1p ROH was present (B)